|
|
Article: Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds.
- Article from:
- AIDS Weekly
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract research organization conducting basic and applied preclinical drug research, announced that several bioactive hits from a set of 15,000 diverse small molecule compounds screened under contract with the National Institute of Allergy and Infectious Diseases (NIAID) exhibit antiviral activity against HIV-1 infected cells. Among the compounds tested at Southern Research using the Trana HIV 201 High-Throughput Screening (HTS) assay, 16 compounds demonstrated inhibition of HIV replication in infected human cells and several of these ...
Related newspaper, magazine, and journal articles:
|
|
Article: Patent No. 7,598,040 Issued on Oct. 6, Assigned to Trana ...
US Fed News Service, Including US State News;
October 9, 2009 ;
445 words
... ... protein synthesis. The inventors were issued U.S. Patent No. 7,598,040 on Oct. 6. The patent has been assigned to Trana Discovery Inc., Cary. According to the abstract released by the U.S. Patent & Trademark Office: "Compositions and methods ...
|
|